Guidance for industry : Q3A impurities in new drug substances.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), International Conference on Harmonisation
Format:	Government Document Conference Proceeding eBook
Language:	English
Published:	Sliver Spring, MD : Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; Center for Biologics Evaluation and Research, [2008]
Subjects:	Drug adulteration. Drugs > Analysis. Drug approval > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS111818